Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
6.82
-1.74 (-20.32%)
Mar 31, 2025, 12:15 PM EDT - Market open
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$835,454
Market Cap
16.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | -9 | -50.00% |
| Dec 31, 2019 | 18 | -1 | -5.26% |
| Dec 31, 2018 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QNTM News
- 5 hours ago - Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms - GlobeNewsWire
- 17 hours ago - Quantum BioPharma Provides Corporate Update - Newsfile Corp
- 3 days ago - Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern - Accesswire
- 11 days ago - Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies - GlobeNewsWire
- 13 days ago - Quantum BioPharma Unaware of Any Material Change - Newsfile Corp
- 6 weeks ago - Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program - GlobeNewsWire
- 7 weeks ago - Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs - GlobeNewsWire
- 7 weeks ago - Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study - GlobeNewsWire